Evidence map›Paper›PMID 24425877›Full record

ArticleThe Journal of biological chemistry2014

CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.

Gina N Calco, Olivia R Stephens, Laura M Donahue, Cynthia C Tsui, Brian A Pierchala

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gina N CalcoFrom the Department of Biologic and Materials Sciences, The University of Michigan School of Dentistry, Ann Arbor, Michigan 48109 and.
Olivia R Stephens
Laura M Donahue
Cynthia C Tsui
Brian A Pierchala
University of Michigan–Ann Arbor · US

Funding

Survival and growth-promotion mechanisms of the GDNF family ligands (GFLs)R01NS058510 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIERCHALA, BRIAN ANTHONY · 2008 to 2012
$1.7M
GDNF and Ret are critical for glomerular development, maintenance, and protectionK08DK084210 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TSUI, CYNTHIA · 2009 to 2013
$777k
NIDDK NIH HHS K08 DK084210NINDS NIH HHS R01 NS058510
6 · The paper itself

Abstract

Ret is the receptor tyrosine kinase for the glial cell line-derived neurotrophic factor (GDNF) family of neuronal growth factors. Upon activation by GDNF, Ret is rapidly polyubiquitinated and degraded. This degradation process is isoform-selective, with the longer Ret51 isoform exhibiting different degradation kinetics than the shorter isoform, Ret9. In sympathetic neurons, Ret degradation is induced, at least in part, by a complex consisting of the adaptor protein CD2AP and the E3-ligase Cbl-3/c. Knockdown of Cbl-3/c using siRNA reduced the GDNF-induced ubiquitination and degradation of Ret51 in neurons and podocytes, suggesting that Cbl-3/c was a predominant E3 ligase for Ret. Coexpression of CD2AP with Cbl-3/c augmented the ubiquitination of Ret51 as compared with the expression of Cbl-3/c alone. Ret51 ubiquitination by the CD2AP·Cbl-3/c complex required a functional ring finger and TKB domain in Cbl-3/c. The SH3 domains of CD2AP were sufficient to drive the Cbl-3/c-dependent ubiquitination of Ret51, whereas the carboxyl-terminal coiled-coil domain of CD2AP was dispensable. Interestingly, activated Ret induced the degradation of CD2AP, but not Cbl-3/c, suggesting a potential inhibitory feedback mechanism. There were only two major ubiquitination sites in Ret51, Lys(1060) and Lys(1107), and the combined mutation of these lysines almost completely eliminated both the ubiquitination and degradation of Ret51. Ret9 was not ubiquitinated by the CD2AP·Cbl-3/c complex, suggesting that Ret9 was down-regulated by a fundamentally different mechanism. Taken together, these results suggest that only the SH3 domains of CD2AP were necessary to enhance the E3 ligase activity of Cbl-3/c toward Ret51.

Indexed as

src Homology DomainsUbiquitinationAdaptor Proteins, Signal TransducingAnimalsCytoskeletal ProteinsGene Knockdown TechniquesGene SilencingLysineMiceMutationNIH 3T3 CellsPhosphorylationPodocytesProtein IsoformsProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-retAdaptor Proteins, Signal TransducingCblc protein, mouseCD2-associated proteinCytoskeletal ProteinsLysineProtein IsoformsProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-retRet protein, mouseUbiquitinNeurodevelopmentNeurotrophic FactorProtein DegradationReceptor Tyrosine KinaseUbiquitination

Identifiers

PMID24425877
PMCPMC3953248
OpenAlexW2001308123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.